APA (7th ed.) Citation

Ridderstråle, M., Rosenstock, J., Andersen, K. R., Woerle, H. J., & Salsali, A. (2018). Empagliflozin compared with glimepiride in metformin‐treated patients with type 2 diabetes: 208‐week data from a masked randomized controlled trial. Diabetes, obesity & metabolism, 20(12), 2768-2777. https://doi.org/10.1111/dom.13457

Chicago Style (17th ed.) Citation

Ridderstråle, Martin, Julio Rosenstock, Knut R. Andersen, Hans J. Woerle, and Afshin Salsali. "Empagliflozin Compared with Glimepiride in Metformin‐treated Patients with Type 2 Diabetes: 208‐week Data from a Masked Randomized Controlled Trial." Diabetes, Obesity & Metabolism 20, no. 12 (2018): 2768-2777. https://doi.org/10.1111/dom.13457.

MLA (9th ed.) Citation

Ridderstråle, Martin, et al. "Empagliflozin Compared with Glimepiride in Metformin‐treated Patients with Type 2 Diabetes: 208‐week Data from a Masked Randomized Controlled Trial." Diabetes, Obesity & Metabolism, vol. 20, no. 12, 2018, pp. 2768-2777, https://doi.org/10.1111/dom.13457.